“I have informed NASCAR that I have requested that the ‘B’ sample be tested, following the steps according to NASCAR’s 2012 rule book regarding this situation. I fully respect NASCAR’s drug usage policy and the reasons they have it.
I am hoping this can get resolved as quickly as possible so that I can get back to driving the No. 22 Penske Racing Dodge. I am sorry that this has caused such a distraction for my Penske Racing team, our sponsors and fans.
Obviously I would never do anything to jeopardize my opportunity here at Penske Racing or to my fellow drivers. I am very conscious about my training and health and would never knowingly take a prohibited drug.”
AJ Allmendinger PR
UPDATE: “In an effort to help our colleagues in the media report on this in a timely and accurate manner, we wanted to provide some additional details regarding AJ’s sample “A” test results. AJ tested positive for a stimulant. He has no idea why the first test was positive, and he has never knowingly taken any prohibited substance. AJ is collecting his medicines and supplements for testing to determine whether an over the counter product caused his positive test. AJ and all of us at Walldinger Racing respect NASCAR’s testing program, and he has requested that his “B” sample be tested as part of the process of getting to the bottom of this. We will have the opportunity to review all of the scientific data surrounding the test following the “B” sample test, but our understanding is that AJ’s test was slightly above the threshold. As of this morning, we have not been given notice of when the testing of the “B” sample will take place. Thanks again for all of the support of our fans, team, and sponsors as we continue working through the process.”
- TEAM CHEVY NASCAR RACE ADVANCE: Talladega Superspeedway - April 17, 2024
- American Sprint Car Series Starts New Chapter at Super Bee Speedway - April 17, 2024
- Big Machine Racing – ‘Dega here we come - April 17, 2024